| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |